Brain-heart connection and the risk of heart attack

Biomedicine and Pharmacotherapy

Volumn 56, Issue SUPPL. 2, 2002, Pages 257-265

  Singh, R B ^a   Kartik, C ^a   Otsuka, K ^b   Pella, D ^c   Pella, J ^c  

^a Medical Hospital and Research Centre Moradabad   (India)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Brain; Cardiac events; Heart; Neural; Psychological; Risk factors

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; ANGIOTENSIN; ANTIOXIDANT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ENDORPHIN; ESTROGEN; FIBRINOLYTIC AGENT; FREE RADICAL; GESTAGEN; HEPARIN; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE 5 NITRATE; MELATONIN; METOPROLOL; NITRIC OXIDE; OMEGA 3 FATTY ACID; RENIN; SEROTONIN; SPIRONOLACTONE; TRIMETAZIDINE; UBIDECARENONE; UBIQUINONE; UNINDEXED DRUG;

ACETYLCHOLINE BRAIN LEVEL; ACUTE HEART INFARCTION; AGGRESSION; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; BIOLOGICAL RHYTHM; BLOOD PRESSURE; BRAIN DEPTH STIMULATION; BRAIN REGION; CARDIOVASCULAR RISK; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; CLINICAL TRIAL; COLD EXPOSURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DIABETES MELLITUS; DIET RESTRICTION; DIETARY INTAKE; DRUG EFFECT; EMOTION; EXERCISE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART EXCITATION; HEART FAILURE; HEART RATE VARIABILITY; HIGH TEMPERATURE; HIPPOCAMPUS; HOSTILITY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPOPHYSIS; INSULIN RESISTANCE; LIFESTYLE; MENTAL STRESS; NONHUMAN; PINEAL BODY; POLLUTION; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SIDE EFFECT; SLEEP WAKING CYCLE; SUDDEN DEATH; SUPRACHIASMATIC NUCLEUS; SYMPATHETIC NERVE; SYMPATHETIC TONE; THORAX PAIN; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; BRAIN; EDITORIAL; HEART; HEART INFARCTION; HEART RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; VASCULARIZATION;

BRAIN; CIRCADIAN RHYTHM; HEART; HEART RATE; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 0036866473     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0753-3322(02)00300-1     Document Type: Article

References (72)

1. Charaka Samhita (Charaka, 600 BC), translated by Sharma PV, Chaukhambha Orientalia, Varanasi, Delhi, 1981.
2. Sushruta Samhita (Sushruta, 600 BC), translated by Bhisagratna Chaukhambha Sanskrit Series Office, Varanasi Vol 1-3, 1999.
3. Atharveda Samhita (3000-5000 BC), William Dwight Whitney, Ed. Charles Pockwell, Lanman, Harvard Oriental Series, Motilal Banarsidass, Delhi, 1984.
4. Pell S, D'Allonzo CA. Acute myocardial infarction in a large industrial population. JAMA 1963;185:831-8.
5. Wennerblom B, Lurje L, Karsson T, Tygesen H, Vahisalo R, Hjamarson A. Circadian variation of heart rate variability and the rate of autonomic change in the morning hours in healthy subjects and angina patients. Int J Cardiol 2001;79:61-9.
6. Churisna SK, Ganelina IE. On the distribution of incidence of acute myocardial within a 24-hour period. Kardiologia 1975;15:115-8.
7. WHO International Study Group. Myocardial Infarction Community Register. Public Health in Europe. Copenhagen, Regional Office for Europe 1976;5:1-232.
8. Singh RB. Can nutrition influence heart rate and blood pressure variability(Abstract). Proceedings of the first international symposium on chronoastrobiology and chronotherapy. Biomedicine and Pharmacother J, Tokyo November 11, 2000:99.
9. Halberg F, Cornelissen G, Halberg J, Fink H, Chen CH, Otsuka K, Watanabe Y, Kumagai Y, Syutkina EV, Kawasaki T, Uezono K, Zaho Z, Schwartzkoft O. Circadian hyper-Amplitude-Tension, CHAT: A disease risk syndrome of antiaging medicine. JAAM 1998;1:239-59.
10. Whiteman MC, Fowkes WGR, Deary IJ. Hostility and the heart. BMJ 1997;315:379-80.
11. Hippisley-Cox J, Fielding K, Pringle M. Depression as a risk factor of coronary artery disease in men: Population based case control study. BMJ 1998;316:1714-9.
12. Singh R. Study of Nutrition, Anxiety, Stress and Behaviour in Relation to Cardiovascular Risk Factors in the Elderly Urban Population of Moradabad. Thesis for PhD. Bareilly, UP, India: Ruhelkhand University; 1998.
13. Morris K. New Day downs for research on circadian rhythms. Lancet 1999;353:990.
14. Inouye ST, Kawamura H. Persistence of circadian rhythmicity in a mammalian hypothalamic island containing the suprachiasmatic nucleus. Proc Nat Acad Sci USA 1979;76:5962-7.
15. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458.
16. Das UN. The brain-lipid heart connection. Nutrition 2001; 17:260-3.
17. Lauritzen I, Blondeau N, Heurteaux C, et al. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000;19:1784-8.
18. Higgins CB, Vatner SF, Braunwald E. Parasympathetic control of the heart. Pharmacol Rev 1973;25:119.
19. Kent KM, Smith ER, Redwood DR, Epstein SE. Electrical stability of the ischemic myocardium: Influences of the heart rate and vagal stimulation. Circulation 1973;47:291.
20. Verrier RL, Rabinowitz SH, Lown B. Vagal and adrenergic interactions and ventricular electrical stability. Clin Res 1975;23:212A.
21. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165.
22. Lown B, Verrier RL, Rabinowitz SH. Neural and psychologic mechanisms and problem of sudden cardiac death. Am J Cardio 1977;139:890.
23. Schwartz, Verrier RL, Lown B. Effects of stellectomy and vagotomy on ventricular refractoryness in dogs. Circ Res 1977;40:536.
24. Randall WC, Rohse WG. The augmentor action of sympathetic cardiac nerves. Circ Res 1956;4:470.
25. Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 1969;217:703.
26. Matta RJ, Verrier RL, Lown B. The repetitive extrasystoles as an index of variability to ventricular fibrillation. Am J Physiol 1976;230:1469-73.
27. Lown B, Verrier RL, Cobalan R. Psychologic stress and threshold for repetitive ventricular response. Science 1973;182:834-8.
28. Matta RJ, Lawler JE, Lown B. Ventricular electrical instability in the conscious dog: Effects of psychologic stress and beta-adrenergic blockade. Am J Cardiol 1976;38:594-8.
29. Corbalan R, Verrier RL, Lown B. Psychologic stress and ventricular arrhythmias during myocardial infarction in the conscious dogs. Am J Cardiol 1974;34:692-6.
30. Antonaccio MJ, Robson RD. Cardiovascular effects of 5-hydroxytryptophanin anaesthetised dogs. J Pharm Pharmacol 1973;25:495-9.
31. Rabinowitz SH, Lown B. Central neurochemical factors related to serotonin metabolism and cardiac ventricular vulnerability for repetitive electrical activity. Am J Cardiol 1978;41:516-20.
32. Engel GL. Sudden and rapid death during psychological stress. Folk lore or Folk wisdom. Ann Intern Med 1971;74:771-6.
33. Taggart P, Carruthers M, Somerville W. Electrocardiograms, plasma catecholamines and lipids and their modification by oxyprenalol, when speaking before an audience. Lancet 1973;2:341-2.
34. Taggart P, Gibbons D, Sommerville W. Some effects of motor car driving on the normal and abnormal heart. Br Med J 1969;4:130-2.
35. Rose KD. The post coronary patient as a spectator sportsman. In: Elliot RS, editor. Stress and the Heart. New York: Futura Publishing Co; 1974. p. 207 p..
36. Lown B, Tykocinski M, Garfein A, Brooks P. Sleep and ventricular premature beats. Circulation 1973;48:691-5.
37. Parkes cm, Benjamin B, Fitzgerald R. Brocken heart: Stetistical study of increased mortality among widowers. Br Med J 1969;1:740-5.
38. Rahe RH, Bennet L, Romo M, Seltanen P, White RJ. Subjects recent life changes and coronary heart disease in Finland. Am J Psychiatry 1973;130:1222-6.
39. Jarvinen KAJ. Can wards rounds be a danger to patients with myocardial infarction. Br Med J 1955;1:318-21.
40. Tofler GH, Stone PH, Maclure M, Edelman E, Davis VG, et al. Analysis of possible triggers of acute myocardial infarction(The MILIS STUDY). Am J Cardiol 1990;66:22-7.
41. Willich SN, Loewel H, Lewis M, et al. TRIMM Study Group. Association of wake time and the onset of myocardial infarction. Z Kardiol 1991;80(Suppl 3):105-12.
42. Singh RB, Pella D, Neki NS, Metsutake G, Niaz MA, Rastogi SS. Mechanisms of acute myocardial infarction(MAMI) study. Biomedicine and Pharmacotherapy 2002 (in press).
43. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743.
44. Czeisler CA, Johnson MP, Duffy JF, et al. Exposure to bright light and darkness to treat physiological maladaptation to night work. N Eng J Med (18) 1990:1253-9.
45. Vaidya AB, Bhatt MA. Chronobiology of ischaemic heart disease events: Relevance of ancient insights in human lifestyle. J Asso Phys India 1999;47:629-30.
46. Mehta S.R., Das S., Karloopia S.D., Mathur P., Dham S.K., Raghunathan D. The circadian pattern of ischaemic heart disese in Indian population. J Asso Phys India 1998;46:767.
47. Davis MJ, Thomas AC. Plaque fissuring, the cause of acute myocardial infarction, sudden ischemic death and cresendo angina. Br Heart J 1985;53:363-73.
48. Davis MJ, Thomas AC. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137-40.
49. Quyyumi AA, Crake T, Wright cm, Mockus LJ, Fox KM. Medical treatment of patients with severe exersional angina: Double blind comparison of beta-blocker, calcium antagonist and nitrate. Br Heart J 1987;57:505-11.
50. Wennerblom B, Lurje L, Karsson T, Tygesen H, Vahisalo R, Hjamarson A. Circadian variation of heart rate variability and the rate of autonomic change in the morning hours in healthy subjects and angina patients. Int J Cardiol 2001;79:61-9.
51. Kukreja RS, Datta BN, Chakravarti RN. Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis 1981:40291-8.
52. Cugini P, Letizia C, Scarvo D. The circadian rhythmicity of serum angiotensin converting enzyme: Its phasic relation with circadian cycle of plasma renin and aldosterone. Chronobiologia 1988;15:229-32.
53. Cugini P, Scibilia G, Cavallini M, Letizia C, et al. Circadian rhythms of renin activity, aldosterone, angiotensin converting enzyme and cortisol in kidney and heart transplantation. Chronobiology, Part A, Wiley-Liss Inc 1990:565-74 p.
54. Veglio F, Pitrandice R, Ossola M, Vignani A, Angili A. Circadian rhythm of the angiotensin converting enzyme activity in serum of healthy adult subjects. Chronobiologia 1997;14:21-5.
55. Watanabe Y, Cornelissen G, Halberg F, Saito Y, Fukuda K, Otsuka K, Kikuchi T. Chronobiometric assessment of autogenic training effects upon blood pressure and heart rate. Perceptual and Motor. Skill 1996;83:1395-410.
56. Christensen JH, Gustenhoff P, Komp E, Aaroe J, Tofgt E, Moller J, Rasmusenn K, Dyerberg J, Schmidt EB. Effect of fish oil on heart rate variability in survivors of myocardial infarction. Br Med J 1996;312:677-8.
57. Christensen JH, Komp E, Aaroe J, Toft E, Moller J, Rasmusen K, Dyerberg J, Schmidt EB. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 1997;79:1670-2.
58. Gudbjamason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern Med 1989;225:117-28 (Suppl).
59. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction. The Indian experiment of infarct survival. Cardiovasc. Drug Ther 1997;11:485-91.
60. Singh RB, Wander GS, Rastogi A, Shukla PK, Mittal A, Sharma JP, Mehrotra SK, Kapoor R, Chopra RK. Randomized, double blind, placebo controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drug Ther 1998;12:347-53.
61. Pepe S, Bogdonor K, Hallaq H, Spurgeon H, Leal A, Lakatta E. Omega-3 polyunsaturated fatty acids modulates dihydropyridine effects on L-type Ca-channels, cytosolic Ca and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci, USA 1994;91:8832-6.
62. Chin JPF. Marine oils and cardiovascular reactivity. Prostaglandins Leukot Essent Fatty Acids 1994;50:211-22.
63. Christensen JH, Christensen MS, Toft E, Dyerberg J, Schmidt EB. Alpha-linolenic acid and heart rate variability. Nutr Metab Cardiovasc Dis 2000;10:57-61.
64. Weydahl A, Cornelissen G, Halberg F, Siegelova J, Kumagai Y, Otsuka K. Chronobiologic optimization of exercise physiology and practice guided by heart rate variability. Scripta Medica(BRNO) 1998;71:215-30.
65. Korkmaz ME, Muderrisoglu H, Ulucam M, Ozin B. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol 2000;86: 649-53.
66. Lanza GA, Giordano A, Pristipino C, Calcagni ml, Meduri G, Trani C, Franceschini R, Crea F, Troncone L. Relationship between myocardial 123I-metaiodobenzyl- guanidine scientigraphic uptake and heart rate variability in patients with syndrome x. Ital Heart J 2000;1:221-5.
67. Christensen JH, Skou HA, Fog L, Hansen V, Vesterlund T, Dyerberg J, Toft E, Schmidt EB. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 2001;103:623-5.
68. Yee KM, Pringle SD, Struthers A. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol 2001;37:1800-7.
69. Aronson D, Burger AJ. Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Ann Noninvasive Electrocardiol 2001;6:98-106.
70. Lin LY, Lin JL, Du mL, Lai LP, Tseng YZ, Huang SK. Reversal of deteriorated fractal behavior of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure. Cardiovasc Electrophysiol 2001; 12:33-5.
71. Ulgen MS, Akdemir O, Toprak N. The effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in early period of acute myocardial infarction. Int J Cardiol 2001;77:255-62.
72. Singh RB, Niaz MA, Kartik C. Can n-3 fatty acids provide myocardial protection by decreasing infarct size and inhibiting atherothrobbosis, Ur Heart J 2001:D62-9 (3 Suppl D).